Answers are grounded in this paper and cite their sources.
Observational analysis shows improved right ventricular contractility and pulmonary artery pressure in a patient with mitral regurgitation and pulmonary hypertension.
Levosimendan is a common inodilator for heart failure management. However, intravenous administration of this drug is associated with side effects (decreased systemic vascular resistance) that leads to systemic hypotension and need for vasopressors. Inhalation of levosimendan prevents side effects of intravenous administration and selectively affects right ventricular contractility and pulmonary vessels. The authors used inhalation of levosimendan in an 83-year-old patient with post-infarction mitral insufficiency and severe pulmonary hypertension before cardiac surgery. To evaluate the effectiveness of this method, the authors used vector analysis and assessed intraventricular blood flows in cardiac chambers using modern capabilities of echocardiography. There was a significant improvement of right ventricular contractility, pulmonary artery pressure and myocardial energy reserves before surgery without catecholamines.
No takes yet. Share an insight, caveat, or question.
Еременко et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: